
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 7.280 | 7.280 | 0.000 |
Shares | 93.820 | 93.820 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 36.440 | 26.300 |
Price to Book | 4.004 | 3.288 |
Price to Sales | 5.828 | 4.479 |
Price to Cash Flow | 25.121 | 20.099 |
Dividend Yield | 1.296 | 2.136 |
5 Years Earnings Growth | 4.766 | 8.150 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.000 | 96.666 |
Consumer Cyclical | 0.890 | 0.679 |
Consumer Defensive | 0.100 | 2.828 |
Number of long holdings: 62
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 8.16 | 65.10 | -2.60% | |
Suzhou Zelgen Biopharma | CNE100003RP1 | 7.99 | 101.24 | -1.42% | |
Salubris Pharm A | CNE100000FW8 | 5.84 | 56.36 | -0.09% | |
Beijing Hotgen | CNE100003P82 | 5.63 | 182.27 | +2.79% | |
Kelun Pharm A | CNE100000PW7 | 5.02 | 34.87 | -0.03% | |
HOB Biotech Group | CNE100004C37 | 4.36 | 155.20 | -2.32% | |
BeOne Medicines | CNE100005XT6 | 3.61 | 273.67 | -4.20% | |
InventisBio | CNE100005Q22 | 3.58 | 28.32 | +2.05% | |
Beijing New Oriental Star Petro Eng | CNE100001X92 | 3.52 | 19.56 | +0.46% | |
Bide Pharmatech | CNE100005NV3 | 3.39 | 64.80 | -2.41% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ABC-CA New Energy Theme mix | 7.67B | 32.85 | -3.02 | - | ||
ABC-CA Industry 4.0 Alloc | 2.68B | 46.19 | 11.53 | 18.31 | ||
ABC-CA Selected Strategies Equity | 2.27B | 13.76 | -1.80 | 8.13 | ||
ABC CA Research Selection Fund | 2.04B | 19.79 | -2.25 | 11.07 | ||
ABC CA Sector Growth Equity Fd A | 1.21B | 17.30 | 0.08 | 3.99 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review